European Archives - Page 343 of 1100 - European Medical Journal

Shaping the Future in Rare Lung Diseases: From Imaging to Patient Management

The main objective was to discuss unmet needs in the diagnosis and management of rare lung diseases, with a particular emphasis on alpha…

Breathing New Life Into Acute Respiratory Care: Proactively Improving Long-Term Outcomes

Approximately 262 million people have asthma globally, with around 1,000 asthma-related deaths every day. In Europe alone…

ERS 2023 Abstract Highlights

They cover key topics, including persistent airflow limitation in paediatric severe asthma, pulmonary rehabilitation, health-related…

Precision Medicine in Airway Diseases: What Can We Offer in the Clinic?

Sanjay Haresh Chotirmall, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, began the session…

Exploring Type 2 Inflammation in Chronic Obstructive Pulmonary Disease

Rabe began the presentation by highlighting two hypothetical patients with different ages, physiologies, and backgrounds to contextualise…

Efficiency Assessment of 15 Nebuliser Systems by the Respirable Drug Delivery Rate: A Comparable Quality Parameter

Nebuliser therapy is a relevant therapy option for respiratory diseases, yet studies have demonstrated a wide variation in nebuliser drug…

Biofilms and Innovations in Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a leading cause of death. This review focuses on the development of biofilms, and…

Non-invasive Management of Atelectasis: A Case Report

The manuscript describes the physiotherapeutic techniques used and collects the main scientific evidence on them. The main purpose…

Anatomical Variant of the Right Upper Lobe Bronchus

The authors present a case of a 77-year-old female, a former smoker with a history of chronic obstructive pulmonary disease who underwent…

Dr Andreas Konieczny on leading with authenticity

Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen, talks to GOLD about moving from big pharma to biotech, his passion for oncology and lessons in leadership.